Tamoxifen ‘keeps breast cancer at bay’ for 20 years

Diagnostic Imaging Services shares a news report that touts research showing that Women who take the drug tamoxifen to prevent breast cancer stand a good chance of keeping the disease at bay for 20 years.

Professor Jack Cuzick, from Queen Mary University of London, who led the International Breast Cancer Intervention Study (Ibis-I) trial, said: “Tamoxifen is a well-established and effective treatment for certain breast cancers, but we now have evidence of its very long-term preventative benefits.

“The preventative effect of tamoxifen is highly significant, with a reduction in breast cancer rates of around a third, and this impact has remained strong and unabated for 20 years. We hope these results will stimulate more women to consider treatment options for breast cancer prevention if they have a family history of the disease or other major risk factors.”